On business segments, the company allotted RON20 million for investments in equipment and the modernization of existing capacities. Funds were earmarked mainly for the production of solid forms and packaging. The company also invested RON7.72 million in research and development (R&D) which enabled it to start the local production for ten new products intended for external markets.
Currently, 50% of Zentiva production is intended for export, to countries like Germany, UK, France, Italy, Switzerland and the Cech Republic.
In 2018, the company reported a consolidated turnover of RON461.4 million and a profit of RON262.6 million.
The Zentiva factory in Bucharest is among the few Romanian businesses in the drugmaking industry that still sell Romanian-made products on the market.